Veradigm | MDRX - Revenu Net

Prix De L'Action
4.58
Variation Quotidienne
-0.07 -1.40%
Mensuellement
1.78%
Annuel
7.76%
Q1 Prévisions
4.44




Revenu Net Changement Date
Alcidion AUD 1.33M 1.21M 2025-12
Ambu A/S DKK 118M 3M 2025-12
Amplifon EUR 6.3M 28.94M 2025-09
Cardinal Health USD 467M 17M 2025-12
Centene USD -1.1B 5.53B 2025-12
Charles River Laboratories USD -276.56M 330.98M 2025-12
Cigna USD 1.23B 55.22B 2025-12
Coloplast 1.4B 522M 2025-12
Computer Programs Systems USD -9.81M 4.76M 2024-09
Convatec Group USD 111.9M 72.6M 2024-12
CVS Health USD 2.94B 6.92B 2025-12
Diasorin EUR 38.26M 9.14M 2025-09
Elevance Health USD 547M 642M 2025-12
General Electric Aerospace USD 2.54B 384M 2025-12
Gulf Medical Proj AED 30.2M 9.34M 2025-12
Humana USD -796M 991M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Laboratory Of America USD 164.7M 96.4M 2025-12
Maximus USD 75.29M 30.69M 2025-09
McKesson USD 1.19B 76M 2025-12
Med Life RON 7.24M 23.18M 2025-09
Molina Healthcare USD -160M 239M 2025-12
Omnicell USD -2.03M 7.49M 2025-12
Oriola-kd EUR -17.9M 19.6M 2025-12
Owens Minor USD -56.33M 93.95M 2025-12
Quest Diagnostics USD 245M 0 2025-12
Rede D'or Sao Luiz BRL 1.17B 301.45M 2025-12
Siemens Healthineers EUR 449M 139M 2025-12
Sonova Holding CHF 188.5M 143.4M 2025-12
Supermax Corporation Bhd MYR -58.44M 76.17M 2025-12
UnitedHealth USD 10M 2.34B 2025-12
Veeva Systems USD 244.2M 8M 2025-12
Veradigm USD -59.82M 74.35M 2022-12
Xerox USD -109M 19M 2025-06